Asked on Healicus
Does CBT-i work better than sleeping pills?
Answer published by a reader on . AI-generated from the sources below; general educational information, not medical advice.
CBT-i produces more durable improvements than sleeping pills and is recommended as the first-line treatment over medication — though in the short term, pills may work faster.
The AASM clinical practice guideline strongly recommends CBT-i as the first choice for chronic insomnia in adults. A meta-analysis of 20 randomised trials (1,162 people) found CBT-i shortened the time to fall asleep by about 19 minutes and reduced night waking by about 26 minutes, with gains that held up over time 2Davidson JR et al., Br J Gen Pract, 2019 — Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomesSystematic review · Br J Gen Pract 2019The findings support the effectiveness of multicomponent CBT-I in general primary care. Future studies should use standard sleep measures, examine daytime symptoms, and investigate the impact of hypnotic tapering interventions delivered in conjunction with CBT-I.Open on pubmed.ncbi.nlm.nih.gov ↗. Sleeping pills (benzodiazepines and "Z-drugs") can produce quicker relief in the first nights, but guidelines recommend discontinuing them — especially in older adults — partly because CBT-i addresses the underlying thought and behaviour patterns that keep insomnia going, whereas pills don't 1Palagini L et al., Sleep Med, 2025 — Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus groupSystematic review · Sleep Med 2025Discontinuation of Hypnotic Benzodiazepines and Z-drugs should be gradual, with dose reductions of 10-25 % each week.Open on pubmed.ncbi.nlm.nih.gov ↗4Fung CH et al., JAMA Intern Med, 2024 — Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialRandomised trial · JAMA Intern Med 2024This randomized clinical trial found that a program combining masked tapering with novel cognitive and behavioral exercises targeting placebo mechanisms improved the percentage of long-term benzodiazepine receptor agonist discontinuation compared with standard CBTI plus an unmasked taper.Open on pubmed.ncbi.nlm.nih.gov ↗.
There's also growing evidence that CBT-i can help people taper off sleep medication they're already using 3Gardner DM et al., JAMA Psychiatry, 2024 — Patient Self-Guided Interventions to Reduce Sedative Use and Improve Sleep: The YAWNS NB Randomized Clinical TrialRandomised trial · JAMA Psychiatry 2024Results of the YAWNS NB randomized clinical trial show that, as a simple, scalable, direct-to-patient intervention, YAWNS-1 substantially reduced BZRA use and improved sleep outcomes. It could be implemented to transform insomnia care for older adults at the population level.Open on pubmed.ncbi.nlm.nih.gov ↗4Fung CH et al., JAMA Intern Med, 2024 — Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical TrialRandomised trial · JAMA Intern Med 2024This randomized clinical trial found that a program combining masked tapering with novel cognitive and behavioral exercises targeting placebo mechanisms improved the percentage of long-term benzodiazepine receptor agonist discontinuation compared with standard CBTI plus an unmasked taper.Open on pubmed.ncbi.nlm.nih.gov ↗.
The main catch: CBT-i takes 4–8 weeks and feels harder before it feels better — sleep restriction (one of its core techniques) causes short-term daytime sleepiness.
Sources
In this answer
Have a follow-up, or a question of your own? Every answer cites Cochrane, EU regulators, guideline bodies or trials in leading journals.